Home » today » Health » Pharmaceutical Industry Reaches Salary Agreements with Unions, INDEC Reports 20.6% CPI Increase | Flu Vaccine Approvals and Executive Moves Highlighted

Pharmaceutical Industry Reaches Salary Agreements with Unions, INDEC Reports 20.6% CPI Increase | Flu Vaccine Approvals and Executive Moves Highlighted

In full short week for him carnavalthe pharmaceutical industry record news of all kinds. Although the improvement of salaries in the sector through the relevant joint agreements were the focus topic.

In the last days the discussions around minimum salary were left in the center of the scene. And in parallel, the pharmaceutical industry managed to reach a understanding with the FATSA union for the parity of the sectorafter delayed conversations. Thus, a increase of the 20.6% for February which disappear al year-end outstanding differential. See FATSA Joint Agreements

In turn, the drugstores nucleated in ADEM they moved in the same direction. He first increase it will be applicable to January salary through a 18.4% that recovers the gap Front of inflation 2023. And the second improvement will be from a 20.6% for February salarywhat charged from March 1 to 5y based on January CPI. As an effect of this negotiationworkers will receive a bimonthly improvement of 42.79% in all the salaries compared to December 2023. See Paritarias Drugstores

All this is the result that this week the INDEC published the data corresponding to the January CPIwhich showed a rise of 20.6%. And in the hygiene basket there were several articles what greatly exceeded this figure. For example, the diapers They were seeded climb 65.3%. Meanwhile, the shampoo increased by 57.1% and the deodorant rose 47.6%. So, three of the only five products of hygiene measured by the INDEC They were enrolled in the top ten of the January increases. See INDEC | View Basket

Besides, the season started of flu vaccines with the first approvals of the ANMAT by 2024. The regulatory body headed by Agustina Visio the gave a thumbs up of a lot of the tetravalent Flucelvax Quad of the Australian Seqirus. And then he gave the OK to two other batches from the same laboratory, in this case for the vaccine Afluria Quad. They all destined for the private channel. See article vaccines.

And the executive moves I also know they went up to the information agenda. In this part of Februaryand despite the carnival holidaysThey registered jumps of all stripes in the organizational charts of pharma. Among them, we can list fines of cycle, cruces, up grades y further. See Passes

In it international levellas to many they continued publishing your financial reports. Some companies who made known their annual balances in recent days were CSL; Zoetis; Biogen y company i. Ver CSL | Ver Zoetis | Ver Biogen | Ver Firmenich

2024-02-19 01:00:06
#Parity #inflation #vaccines #passes

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.